Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-01-04 @ 1:36 PM
Study NCT ID:
NCT02250157
Status:
COMPLETED
Last Update Posted:
2022-02-22
First Post:
2014-09-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies
Sponsor:
Athenex, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-04
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-22
First Submit QC Date:
None
Study First Post Date:
2014-09-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-02-22
Last Update Post Date Type:
ACTUAL